Lynn-Marie Morski interviewed Jules about the Challenging Psychedelic Experiences Project
Simon Doherty interviewed Jules Evans for this feature on psychedelic harms and risks
Floris Wolswijk interviewed Anna Lutkajtis and myself on our study of integration challenges after a psychedelic retreat.
Psychedelic therapy is becoming increasingly popular, and has been tried by Prince Harry. But we need to learn more about risks and how to manage them, writes John Naish
An interview with Jules Evans for UC Berkeley's Microdose newsletter
Before psychedelic therapy and services becomes widely available, there needs to be a better understanding of all the ways these experiences can go wrong, writes Shayla Love
Regulators face new challenges over whether - and how - to allow people to access mind-altering drugs to treat mental health conditions, writes Helen Collis
As psychedelic therapy trials get bigger and the drugs become more accessible, researchers need to start talking about their potential adverse effects., writes Grace Browne
Psychedelic companies and investors should invest to learn about and protect people from the risks of psychedelic therapy writes Jules Evans